Docket Room.
SF 4419·MN·senate

Various prescription drug transaction, coverage, and data provisions modifications

FailedFiled Mar 12, 2026
Sponsor: Wiklund
Latest Action

Comm report: To pass as amended and re-refer to

Apr 7, 2026

Email me when SF 4419 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SF 4419. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill would require drug manufacturers, pharmacies, PBMs and wholesale distributors to report detailed pricing and usage data for drugs deemed of substantial public interest. It also standardizes electronic prior‑authorization requests, tightens HMO network‑notification requirements, and expands definitions to include stand‑alone dental plans and biosimilars. The measures aim to increase transparency and simplify administration, but the bill did not pass.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SF 4419

3 free questions a day, no account

Hearings

History

  1. Comm report: To pass as amended and re-refer to Health and Human Services
  2. Comm report: To pass as amended and re-refer to Commerce and Consumer Protection
  3. Referred to Health and Human Services
  4. Introduction and first reading

Sponsors

  • Wiklund · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SF 4419 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SF 4419 free

Or ask your AI assistant about SF 4419 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice